Dawson Luke P, Dinh Diem, Duffy Stephen, Brennan Angela, Clark David, Reid Christopher M, Blusztein David, Stub Dion, Andrianopoulos Nick, Freeman Melanie, Oqueli Ernesto, Ajani Andrew E
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Victoria, Australia.
Resuscitation. 2020 May;150:121-129. doi: 10.1016/j.resuscitation.2020.03.003. Epub 2020 Mar 21.
Out-of-hospital cardiac arrest (OHCA) is frequently associated with ST-elevation myocardial infarction (STEMI) and has a high mortality. We aimed to identify differences in characteristics and very long-term outcomes for STEMI patients with and without OHCA managed with percutaneous coronary intervention (PCI).
We analysed data from 12,637 PCI patient procedures for STEMI in the multi-centre Melbourne Interventional Group registry between January 2005 and December 2018. Multivariable models examined associations with OHCA presentation and 30-day mortality. Long-term outcomes were assessed through linkage with the Australian National Death Index.
Compared with patients without OHCA (N = 11,580), patients with OHCA (N = 1057) were younger, more often male, had less cardiovascular risk factors, and more often presented with cardiogenic shock. OHCA preceded an increasing proportion of STEMI PCI cases from 2005 to 2018 (2.4% vs. 9.2%). Factors independently associated with OHCA presentation were younger age, male gender, prior valve surgery, multi-vessel disease, LAD culprit, small vessel diameter, and renal impairment on presentation. Patients with OHCA had lower procedural success, higher rates of bleeding and stroke, larger infarct size (measured by peak CK), and higher 30-day mortality (37% vs. 5%; all p < 0.05). Cardiogenic shock, renal impairment and lower ejection fraction were independently associated with 30-day mortality. Long-term mortality was 44% vs. 20% (median follow-up 4.6 years), with Cox regression analysis demonstrating no difference in survival if patients survived beyond 30 days (HR 1.18, 95% CI 0.95-1.47).
OHCA has a high short-term mortality and precedes an increasing proportion of STEMI PCI cases. Thirty-day survivors have an excellent long-term prognosis.
院外心脏骤停(OHCA)常与ST段抬高型心肌梗死(STEMI)相关,且死亡率很高。我们旨在确定接受经皮冠状动脉介入治疗(PCI)的合并或未合并OHCA的STEMI患者在特征和极长期结局方面的差异。
我们分析了2005年1月至2018年12月期间多中心墨尔本介入组登记处12,637例STEMI患者PCI手术的数据。多变量模型研究了与OHCA表现和30天死亡率的关联。通过与澳大利亚国家死亡指数联动评估长期结局。
与未发生OHCA的患者(N = 11,580)相比,发生OHCA的患者(N = 1057)更年轻,男性比例更高,心血管危险因素更少,且更常表现为心源性休克。从2005年到2018年,OHCA在STEMI PCI病例中所占比例呈上升趋势(2.4%对9.2%)。与OHCA表现独立相关的因素包括年龄较小、男性、既往瓣膜手术、多支血管病变、左前降支罪犯血管、小血管直径以及就诊时肾功能损害。发生OHCA的患者手术成功率较低,出血和中风发生率较高,梗死面积较大(通过肌酸激酶峰值测量),30天死亡率较高(37%对5%;所有p<0.05)。心源性休克、肾功能损害和较低的射血分数与30天死亡率独立相关。长期死亡率为44%对20%(中位随访4.6年),Cox回归分析表明,如果患者存活超过30天,生存率无差异(风险比1.18,95%置信区间0.95 - 1.47)。
OHCA短期死亡率高,且在STEMI PCI病例中所占比例呈上升趋势。30天幸存者长期预后良好。